Court throws out Abbott AIDS-drug claims

Abbott Laboratories won a federal appeals court ruling dismissing claims that the company maintained a monopoly and overcharged for its HIV medicine Norvir, but still faces suits from competitors and drug-buyers over the price of the drug. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.